Assessing Willingness to Pay for HPV Vaccine among Women of known HIV Status in Lagos

Simple item page
dc.contributor.authorDorinda ODONGHANRO
dc.date.accessioned2024-05-29T13:12:43Z
dc.date.available2024-05-29T13:12:43Z
dc.date.issued2022-12
dc.description.abstractThe knowledge and experience to prevent HPV-related diseases have been established especially in developed countries. Globally, the HPV vaccine has been proven to be effective in preventing especially HR-HPV 16 and 18 and is licensed for use. However, it has not been included among the vaccines given for free in National Immunization Program in Nigeria. The aim of this study is to investigate the knowledge of cervical cancer prevention and explore the willingness to pay for the HPV vaccine among women of known HIV status in Lagos State. In this cross-sectional study, investigators collected data by making use of a semi-structured questionnaire containing both closed and open-ended questions, The data were analyzed by the investigators using the statistical package SPSS version 27.0 (SPSS Inc. Chicago, IL). P values < 0.05 was considered statistically significant and ethical approval was obtained from the ethics committee of NIMR and LCU for this study. A total of 233 respondents participated in the study. The study findings showed the knowledge of HPV to be 33% which is below average. Among sources of information about HPV, health workers (17.0%) and friends (0.4%) recorded the highest and lowest respectively. Knowledge of cervical cancer among respondents was 68% and with major sources of information about the disease having health workers (69.7%) and friends (2.3%) from highest to lowest. Knowledge of the cervical cancer vaccine was 22.8% for the 233 respondents. Furthermore, findings showed a significant correlation between respondents’ knowledge of the vaccine and their willingness to pay for the HPV vaccine. Knowledge and positive attitude towards HPV and HPV vaccine is a key driver that plays an important role in HPV vaccine acceptance. Though cervical cancer is a preventable and treatable cancer, it requires a broadly integrated and sustained effort by multiple stakeholders before meaningful progress can be achieved. Keywords: HIV-positive, Cervical cancer, HPV (Human papillomavirus), Vaccine Word Count: 302
dc.identifier.citationKate Turabian
dc.identifier.otherMPH
dc.identifier.urihttps://repository.lcu.edu.ng/handle/123456789/415
dc.language.isoen
dc.publisherLead City University
dc.relation.ispartofseriesM.PH
dc.subjectHIV-positive
dc.subjectCervical cancer
dc.subjectHPV (Human papillomavirus)
dc.subjectVaccine
dc.titleAssessing Willingness to Pay for HPV Vaccine among Women of known HIV Status in Lagos
dc.title.alternativeIssues and Lessons
dc.typeThesis

Files

Original bundle
Now showing 1 - 3 of 3
No Thumbnail Available
Name:
Dorinda ODONGHANRO Preliminary page.pdf
Size:
117.85 KB
Format:
Adobe Portable Document Format
Download
No Thumbnail Available
Name:
Dorinda ODONGHANRO Thesis.pdf
Size:
933.01 KB
Format:
Adobe Portable Document Format
Download
No Thumbnail Available
Name:
Dorinda Odonghanro Title Page.pdf
Size:
32.96 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download

Collections

Department of Public Health